Literature DB >> 18602061

Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats.

A P Ligeiro de Oliveira1, R Lazzarini, G Cavriani, W M Quinteiro-Filho, W Tavares de Lima, J Palermo-Neto.   

Abstract

The effects of single or repeated amphetamine (AMPH) treatment and those of AMPH withdrawals on immune-mediated lung inflammatory response were studied in rats. Two experiments were done. In the first, rats egg-albumin (OVA) sensitized were singularly or repeatedly (21 days, once daily) treated with AMPH (1.0 mg/kg) or with a similar number and volume of 0.9% NaCl. The OVA aerosol challenge was performed 12 h after the single or last repeated AMPH treatment and also 72 and 120 h after AMPH withdrawal. In the second experiment, the effects of reserpine (1.0 mg/kg/day for 5 consecutive days) on single AMPH actions on lung allergic response of rats were analyzed. Single and repeated AMPH treatment induced opposite actions on Bronchoalveolar lavage fluid (BAL) cellularity of allergic rats: single treatment decreased and repeated treatment increased the total number of cells as well as those of macrophages, neutrophils and eosinophils. Our data also showed that single but not repeated AMPH treatment decreased the number of neutrophils, monocytes and lymphocytes in the peripheral blood, and increased the total number of bone marrow cells in rats sensitized and challenged with OVA. Furthermore, it was shown that reserpine treatment precluded the effects of single AMPH treatment on cellular migration to the lung of OVA-sensitized and challenged rats. It was concluded that AMPH effects on lung inflammatory response and cell recruitment to the lung in allergic rats rely at least partially on corticosterone serum levels. The possible involvement of vesicular monoamine transporter type 2 (VMAT2) with these observed effects was discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602061     DOI: 10.1016/j.intimp.2008.03.013

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  3,4-methylenedioxymethamphetamine (MDMA--Ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to Listeria monocytogenes infection in mice.

Authors:  V Ferraz-de-Paula; A Ribeiro; J Souza-Queiroz; M L Pinheiro; J F Vecina; D P M Souza; W M Quinteiro-Filho; R L M Moreau; M L S Queiroz; J Palermo-Neto
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-12       Impact factor: 4.147

2.  α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice.

Authors:  Ana Paula L D'Almeida; Maria T Pacheco de Oliveira; Éverton T de Souza; Diego de Sá Coutinho; Bianca T Ciambarella; Cristiano R Gomes; Thatiana Terroso; Sílvia S Guterres; Adriana R Pohlmann; Patrícia Mr Silva; Marco A Martins; Andressa Bernardi
Journal:  Int J Nanomedicine       Date:  2017-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.